✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Caplin Point Laboratories Ltd.

CAPLIPOINT

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹17,822 Cr.
P/E
31.54

Caplin Point Laboratories Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
17,822 Cr
PE
PE
31.54
Prom Holding
Prom Holding
70.56 %
ROE (%)
ROE (%)
18.81
ROCE (%)
ROCE (%)
23.36
Div Yield (%)
Div Yield (%)
0.36
Sales
Sales
1,988 Cr
OPM (%)
OPM (%)
33.83 %
Debt to Equity
Debt to Equity
0.00
View more
Edit Ratio's
About
Caplin Point Laboratories was established in 1990 to manufacture a range of ointments, creams … Read more
Low
1551
52W Range
High
2636
  • Caplin Point Lab
  • Gufic Biosciences
  • Gland Pharma
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates
Custom financial statementNew
Edit rows
Forensics

9 Yes

Positive for this company

2 Neutral

Neutral for this company

6 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Distribution Channel

Manufacturing Break-Up

Operational Metrics

    locked
    Select a Metric
    • Number of ANDA's Filed in USA (.)
      Source
    • Number of ANDA's Approved By USFDA (.)
      Source
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    Corporate Actions
    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less
    FAQs on Caplin Point Laboratories Ltd. Business

    Established in 1990, Caplin Point Laboratories is a mid-sized company in India manufacturing APIs, finished formulations, and engaging in research & development, clinical research, and global marketing.

    Caplin Point Lab major competitors are Gufic Biosciences, Gland Pharma, Jubilant Pharmova, Alembic Pharma, Natco Pharma, Eris Lifesciences, Astrazeneca Pharma I.
    Market Cap of Caplin Point Lab is ₹17,822 Crs.
    While the median market cap of its peers are ₹18,815 Crs.

    Caplin Point Lab seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    View FAQ's On Shareprice
    Company Filing
    Discussions & Analysis
    Caplin Point Laboratories Ltd.
    Analysis: Caplin Point Laboratories - Dr Vijay Malik
    View the discussion on ValuePickr
    Data Backed Look At Caplin Steriles - Chins
    Accounting Issues In Caplin Point - ValuePickr
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    GLP-1: The Drug Redefining Diabetes, Obesity, and Pharma’s Future - Perpetuity
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
    Ideas Dashboard
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material